ST. LOUIS—January 14, 2008--GenoMed (OTC Pink Sheets GMED), a Next Generation Disease Management company whose business is public health™, announced that its CEO, David Moskowitz MD, has been selected to chair two upcoming conferences in London, England put on by Visiongain (www.visiongain.com).
